Asthma drug HBM9378 passes first safety check in healthy people
NCT ID NCT05790694
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested a single injection of HBM9378 in 50 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat asthma but to gather safety and drug-level data. Participants were healthy, not asthma patients, so no direct benefit was expected.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Fifth People's Hospital of Chengdu
Sichuan, Chengdu, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI and a smartphone app may let kids with asthma skip clinic visits
- Allergy tablets under the tongue may cut hay fever drug use for years, massive real-world study suggests
- Short steroid course after first wheeze may stop asthma before it starts
- New antibody drug aims to tame Hard-to-Control asthma
- New asthma drug aims to improve breathing without daily pills
- Scientists compare two formulations of a potential asthma treatment